The Coretec Group Inc. (CRTG) 10-Q 14 Nov 19 2019 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 14, 2019
Document Information [Line Items]
Entity Registrant Name	CORETEC GROUP INC.
Entity Central Index Key	0001375195
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		70,190,699
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash	$ 8,681	$ 4,001
Prepaid expenses	87,511	37,237
Total current assets	96,192	41,238
Property and equipment, net	315	882
Other assets:
Patents, net	1,159,312	1,219,484
Goodwill	166,000	166,000
Deposits-other	2,315	2,315
Total other assets	1,327,627	1,387,799
Total Assets	1,424,134	1,429,919
Current liabilities:
Notes payable - related party, net of discount	2,017,434	1,702,300
Notes and debentures payable	119,586	94,764
Accounts payable and accrued expenses	690,346	597,843
Accrued interest payable - related party	650,423	468,260
Accrued interest payable	25,844	26,051
Total current liabilities	3,503,633	2,889,218
Total Liabilities	3,503,633	2,889,218
Stockholders' deficiency:
Preferred stock, Series A convertible, $0.0002 par value, 500,000 shares authorized; 345,000 shares issued and outstanding at September 30, 2019 and December 31, 2018	69	69
Common stock $0.0002 par value, 1,500,000,000 shares authorized; 70,190,699 and 68,474,520 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively	14,038	13,695
Additional paid-in capital	3,065,763	2,166,745
Accumulated deficit	(5,159,369)	(3,639,808)
Total Stockholders' Deficiency	(2,079,499)	(1,459,299)
Total Liabilities and Stockholders' Deficiency	$ 1,424,134	$ 1,429,919

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2019	Dec. 31, 2018
Preferred stock, par value (in dollars per share)	$ 0.0002	$ 0.0002
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	345,000	345,000
Preferred stock, shares outstanding (in shares)	345,000	345,000
Common stock, par value (in dollars per share)	$ 0.0002	$ 0.0002
Common stock, shares authorized (in shares)	1,500,000,000	1,500,000,000
Common stock, shares issued (in shares)	70,190,699	68,474,520
Common stock, shares outstanding (in shares)	68,474,520	68,474,520

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income:
Revenue
Expenses:
Research and development	20,057	20,057	60,172	62,157
General and administrative	874,122	158,908	1,229,378	592,037
Interest	41,209	100,858	230,011	293,636
Total expenses	935,388	279,823	1,519,561	947,830
Other income:
Gain on settlement of accounts payable				139,789
Net loss	$ (935,388)	$ (279,823)	$ (1,519,561)	$ (808,041)
Loss per share:
Basic and diluted (in dollars per share)	$ (0.013)	$ (0.004)	$ (0.022)	$ (0.012)
Weighted average shares outstanding, basic and diluted (in shares)	70,103,698	68,146,829	69,358,355	67,726,410

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders' Deficiency (Unaudited) - USD ($)	3 Months Ended						9 Months Ended		52 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019
Preferred Stock [Member] | Series A Preferred Stock [Member]
Balance (in shares)	345,000	345,000	345,000	345,000	345,000	345,000	345,000
Balance	$ 69	$ 69	$ 69	$ 69	$ 69	$ 69	$ 69
Common stock issued for liabilities (in shares)
Common stock issued for liabilities
Net loss
Common stock issued for services (in shares)
Common stock issued for services
Options issued for compensation and services
Warrants exercised
Convertible securities converted to common stock (in shares)
Convertible securities converted to common stock
Balance (in shares)	345,000	345,000	345,000	345,000	345,000	345,000	345,000	345,000	345,000
Balance	$ 69	$ 69	$ 69	$ 69	$ 69	$ 69	$ 69	$ 69	$ 69
Common Stock [Member]
Balance (in shares)	69,919,674	68,673,537	68,474,520	67,979,605	67,582,970	66,785,428	68,474,520
Balance	$ 13,984	$ 13,735	$ 13,695	$ 13,596	$ 13,517	$ 13,357	$ 13,695
Common stock issued for liabilities (in shares)		273,469	199,017			552,924
Common stock issued for liabilities		$ 54	$ 40			$ 111
Net loss
Common stock issued for services (in shares)	271,025	972,668		199,543
Common stock issued for services	$ 54	$ 195		$ 40
Options issued for compensation and services
Warrants exercised
Convertible securities converted to common stock (in shares)					396,635	244,618
Convertible securities converted to common stock					$ 79	$ 49
Balance (in shares)	70,190,699	69,919,674	68,673,537	68,179,148	67,979,605	67,582,970	70,190,699	68,179,148	70,190,699
Balance	$ 14,038	$ 13,984	$ 13,735	$ 13,636	$ 13,596	$ 13,517	$ 14,038	$ 13,636	$ 14,038
Additional Paid-in Capital [Member]
Balance	2,215,201	2,174,567	2,166,745	2,141,838	2,117,111	2,020,642	2,166,745
Common stock issued for liabilities		11,138	7,822			71,768
Net loss
Common stock issued for services	10,062	29,496		11,954
Options issued for compensation and services	840,500
Warrants exercised					24,581	24,525
Convertible securities converted to common stock					146	176
Balance	3,065,763	2,215,201	2,174,567	2,153,792	2,141,838	2,117,111	3,065,763	2,153,792	3,065,763
Retained Earnings [Member]
Balance	(4,223,981)	(3,938,131)	(3,639,808)	(3,121,555)	(2,931,891)	(2,593,337)	(3,639,808)
Common stock issued for liabilities
Net loss	(935,388)	(285,850)	(298,323)	(279,823)	(189,664)	(338,554)
Common stock issued for services
Options issued for compensation and services
Warrants exercised
Convertible securities converted to common stock
Balance	(5,159,369)	(4,223,981)	(3,938,131)	(3,401,378)	(3,121,555)	(2,931,891)	(5,159,369)	(3,401,378)	(5,159,369)
Balance	(1,994,727)	(1,749,760)	(1,459,299)	(966,052)	(801,194)	(559,269)	(1,459,299)
Common stock issued for liabilities		11,192	7,862			71,879
Net loss	(935,388)	(285,850)	(298,323)	(279,823)	(189,664)	(338,554)	(1,519,561)	(808,041)	5,159,369
Common stock issued for services	10,116	29,691		11,994				11,994
Options issued for compensation and services	840,500
Warrants exercised					24,581	24,525
Convertible securities converted to common stock					225	225
Balance	$ (2,079,499)	$ (1,994,727)	$ (1,749,760)	$ (1,233,881)	$ (966,052)	$ (801,194)	$ (2,079,499)	$ (1,233,881)	$ (2,079,499)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash Flows from Operating Activities
Net loss	$ (1,519,561)	$ (808,041)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	567	567
Amortization - intangible assets	60,172	60,172
Amortization - debt discount	45,134	135,333
Common stock issued for services	39,807	11,994
Options issued for services	724,631
Gain on settlement of accounts payable		(139,789)
Change in:
Prepaid expenses	11,229	32,139
Accounts payable and accrued liabilities	409,381	138,249
Net cash used in operating activities	(228,640)	(569,376)
Cash Flows from Financing Activities
Payments on insurance premium financing	(36,680)	(25,764)
Proceeds from exercise of warrants		23,765
Proceeds from notes payable-related party	270,000	110,001
Net cash provided by financing activities	233,320	108,002
Net change in cash	4,680	(461,374)
Cash, beginning of period	4,001	470,630
Cash, end of period	8,681	9,256
Supplemental Disclosure of Cash Flow Information
Cash paid during the period for interest	2,921	1,898
Non-Cash Investing and Financing Activities
Debentures and warrants converted to common stock		25,791
Options issued for accounts payable	115,869
Common stock issued for liabilities	19,054	71,879
Common stock issued for services		$ 11,994

Note 1 - Business Organization,

Note 1 - Business Organization, Nature of Business and Basis of Presentation	9 Months Ended
	Sep. 30, 2019
Notes to Financial Statements
Business Description and Basis of Presentation [Text Block]	Note 1 Nature of Business The Coretec Group Inc. (the “Group”) (formerly 3DIcon “3DIcon” August 11, 1995, August 1, 2003 3DIcon 2001, 360 January 1, 2001, 3DIcon’s 3D Coretec Industries, LLC (“Coretec”), a wholly owned subsidiary of the Group (collectively the “Company”), was organized on June 2, 2015 not Basis of Presentation The accompanying condensed consolidated financial statements of the Company have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not 10 may not may

Note 2 - Going Concern and Mana

Note 2 - Going Concern and Management's Plans	9 Months Ended
	Sep. 30, 2019
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	Note 2 The Company has realized a cumulative net loss of $5,159,369 June 2, 2015) September 30, 2019, $3,407,441, no The ability of the Company to continue as a going concern depends on the successful completion of the Company's capital raising efforts to fund the development of its planned products. The Company intends to continue to raise additional capital through grants and debt and equity financings. There is no may not may The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplates the continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the condensed consolidated financial statements do not not

Note 3 - Summary of Significant

Note 3 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2019
Notes to Financial Statements
Significant Accounting Policies [Text Block]	Note 3 Principles of Consolidation The condensed consolidated financial statements include the accounts of the Group and its wholly owned subsidiary, Coretec. Intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used. Long-Lived Assets Long-lived assets, such as property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not first not third Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instrument held by the Company: Current assets and current liabilities Notes payable - Beneficial Conversion Feature of Convertible Notes Payable The Company accounts for convertible notes payable in accordance with the guidelines established by the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 470 20, The beneficial conversion feature of a convertible note is credited to additional paid-in-capital. The intrinsic value is recorded in the consolidated financial statements as a debt discount and such discount is amortized over the expected term of the convertible note and is charged to interest expense. Basic and Diluted Loss Per Common Share Basic loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or other instruments to issue common stock were exercised or converted into common stock. Basic and diluted loss per common share are calculated the same for all periods presented due to the net loss. The following securities are excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: September 30, 2019 2018 Options 20,716,557 2,883,379 Warrants 61 1,061 Series A convertible preferred stock 115,000 115,000 Convertible debentures 253,106,815 166,249,033 Total potentially dilutive shares 273,938,433 169,248,473 Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the condensed consolidated financial statements are issued. Based upon the evaluation, the Company did not 6. Recent Accounting Pronouncements The following is a summary of recent accounting pronouncements that are relevant to the Company: In February 2016, No. 2016 02, Leases (Topic 842 ) December 15, 2018, January 1, 2019, 842 not 12 no In January 2017, 2017 04, Intangibles – Goodwill and Other (Topic 350 ): Simplifying the Test for Goodwill Impairment 2 2, December 15, 2019, January 1, 2017 not In June 2018, 2018 07, Improvements to Nonemployee Share-Based Payment Accounting December 15, 2018. 2018 07 January 1, 2019 not In July 2019, 2019 07, 2019 07 2019 07 not

Note 4 - Debentures and Notes P

Note 4 - Debentures and Notes Payable	9 Months Ended
	Sep. 30, 2019
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 4 September 30, December 31, 2019 2018 Notes and debentures payable: 6.05% Insurance premium finance agreement due July 2019 $ - $ 31,089 6.30% Insurance premium finance agreement due July 2020 55,911 - 4.75% Convertible debenture due September 2019 (see Note 6) 63,675 63,675 Total notes and debentures payable $ 119,586 $ 94,764 Notes payable - related party: 14% Term loan due December 2019 $ 374,993 $ 374,993 14% Term loan due December 2019 756,500 621,500 14% Term loan due December 2019 535,941 400,941 7% Convertible promissory note due December 2019, net 250,000 228,627 7% Convertible promissory note due December 2019, net 100,000 76,239 Total notes payable - related party $ 2,017,434 $ 1,702,300 6.05% July 2019 The Company entered into an insurance financing agreement in September 2018 $48,855. eleven $4,441 July 2019. $31,089 nine September 30, 2019. 6. 3 % Insurance premium finance agreement, due July 20 20 The Company entered into an insurance financing agreement in September 2019 $61,503. eleven $5,591 July 2020. $5,591 nine September 30, 2019. 4.75% September 2019 On November 3, 2006, 4.75% $100,000, December 31, 2014 September 30, 2019 61 $114,450 October 15, 2019 ( 6 14% December 2019, On April 18, 2016, $100,000. 1.167% September 30, 2019 December 31, 2019. $374,993 $274,993 September 30, 2019. 2017, 14% December 2019, On February 24, 2016, $300,000. 1.167% September 30, 2019 December 31, 2019. $756,500 $456,500 September 30, 2019. 2017, 14% December 2019, On June 1, 2015, $500,000 1.167% $535,941 $35,941 September 30, 2019. 2019, September 30, 2019 December 31, 2019. 7% December 2019, On March 30, 2017, 7% $250,000, March 1, 2019 ( December 31, 2019. eight 8% not two March 7, 2017, not not may may $250,000 $21,373 $97,830 nine September 30, 2019 2018 7% December 2019, On June 21, 2017, 7% $100,000, June 21, 2019 December 31, 2019. four 4% not two March 7, 2017, not not may may $100,000 $23,761and $37,503 nine September 30, 2019 2018

Note 5 - Commitments and Contin

Note 5 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 5 Options Stock options for employees, directors or consultants that vest immediately, are valued at the date of award, which does not The estimated fair value of options for common stock granted is determined using the Black-Scholes option pricing model. The expected dividend yield is based on the average annual dividend yield as of the grant date. Expected volatility is based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option is based on historical exercise behavior and expected future experience. In August 2019, 20,500,000 $840,500. $840,500 $0 337.19% 1.52% five The following table summarizes the Company’s option activity during the nine September 30, 2019: Weighted Weighted Average Average Remaining Aggregate Number of Exercise Life Intrinsic Options Price In Years Value Outstanding, December 31, 2018 216,557 $ 3.51 8.26 $ - Granted 20,500,000 0.041 4.86 - Outstanding, September 30, 2019 20,716,557 $ 0.077 7.26 $ - Exercisable, September 30, 2019 20,716,557 $ 0.077 7.26 $ - The following table summarizes the Company’s options as of September 30, 2019: Options Outstanding Options Exercisable Weighted Outstanding Average Exercisable Exercise Number of Remaining Life Number of Price Options In Years Options $ 0.24 208,160 7.75 208,160 $ 52.50 4,383 .75 4,383 $ 70.26 3,449 2.75 3,449 $ 420.00 565 1.65 565 $ 0.041 20,500,000 4.86 20,500,000 Total 20,716,557 4.89 20,716,557 Litigation, Claims, and Assessments The Company may not Office Lease The Company has an office lease in Tulsa, Oklahoma. As the lease is month-to-month and cancellable at any time, it is not $17,820 $17,358 nine September 30, 2019 2018

Note 6 - Subsequent Events

Note 6 - Subsequent Events	9 Months Ended
	Sep. 30, 2019
Notes to Financial Statements
Subsequent Events [Text Block]	Note 6 Notes payable-related part y Subsequent to September 30, 2019, September 30, 2019 December 31, 2019. On October 15, 2019, $106,483 $ 125,000 $3,750 $6,250 $8,157 first $2,500,000 October 11, 2019, The Credit Agreement and Note, among other things, provide for borrowings by the Company from the Lender in an aggregate principal amount of up to $2,500,000, October 2019 January 2021 $125,000 $175,000 April 2020. 10% 3% $75,000 Pursuant to the Credit Agreement and Note, the Lender has the right to convert all or part of the Note to shares of common stock of the Company at $0.043, seventy 70% fifteen 15 may In addition, as an inducement to enter into the Credit Agreement and to fund each advance thereunder, the Company issued to the Lender a warrant (the “Warrant”) to purchase up to 3,000,000 $0.052 150,000 210,000 October 2019 April 2020 The estimated value of the warrants issued with the October $3,615 $0.0241 $3,615 $0 342.48% 1.58% five 3,000,000 $72,300 five 4.75% e September 30, 2019 Subsequent to September 30, 2019, 4.75% $63,675 $23,565.

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Group and its wholly owned subsidiary, Coretec. Intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]	Long-Lived Assets Long-lived assets, such as property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not first not third
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instrument held by the Company: Current assets and current liabilities Notes payable -
Debt, Policy [Policy Text Block]	Beneficial Conversion Feature of Convertible Notes Payable The Company accounts for convertible notes payable in accordance with the guidelines established by the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 470 20, The beneficial conversion feature of a convertible note is credited to additional paid-in-capital. The intrinsic value is recorded in the consolidated financial statements as a debt discount and such discount is amortized over the expected term of the convertible note and is charged to interest expense.
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Loss Per Common Share Basic loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or other instruments to issue common stock were exercised or converted into common stock. Basic and diluted loss per common share are calculated the same for all periods presented due to the net loss. The following securities are excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: September 30, 2019 2018 Options 20,716,557 2,883,379 Warrants 61 1,061 Series A convertible preferred stock 115,000 115,000 Convertible debentures 253,106,815 166,249,033 Total potentially dilutive shares 273,938,433 169,248,473
Subsequent Events, Policy [Policy Text Block]	Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the condensed consolidated financial statements are issued. Based upon the evaluation, the Company did not 6.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements The following is a summary of recent accounting pronouncements that are relevant to the Company: In February 2016, No. 2016 02, Leases (Topic 842 ) December 15, 2018, January 1, 2019, 842 not 12 no In January 2017, 2017 04, Intangibles – Goodwill and Other (Topic 350 ): Simplifying the Test for Goodwill Impairment 2 2, December 15, 2019, January 1, 2017 not In June 2018, 2018 07, Improvements to Nonemployee Share-Based Payment Accounting December 15, 2018. 2018 07 January 1, 2019 not In July 2019, 2019 07, 2019 07 2019 07 not

Note 3 - Summary of Significa_2

Note 3 - Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2019
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	September 30, 2019 2018 Options 20,716,557 2,883,379 Warrants 61 1,061 Series A convertible preferred stock 115,000 115,000 Convertible debentures 253,106,815 166,249,033 Total potentially dilutive shares 273,938,433 169,248,473

Note 4 - Debentures and Notes_2

Note 4 - Debentures and Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2019
Notes Tables
Schedule of Long-term Debt Instruments [Table Text Block]	September 30, December 31, 2019 2018 Notes and debentures payable: 6.05% Insurance premium finance agreement due July 2019 $ - $ 31,089 6.30% Insurance premium finance agreement due July 2020 55,911 - 4.75% Convertible debenture due September 2019 (see Note 6) 63,675 63,675 Total notes and debentures payable $ 119,586 $ 94,764 Notes payable - related party: 14% Term loan due December 2019 $ 374,993 $ 374,993 14% Term loan due December 2019 756,500 621,500 14% Term loan due December 2019 535,941 400,941 7% Convertible promissory note due December 2019, net 250,000 228,627 7% Convertible promissory note due December 2019, net 100,000 76,239 Total notes payable - related party $ 2,017,434 $ 1,702,300

Note 5 - Commitments and Cont_2

Note 5 - Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2019
Notes Tables
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	Weighted Weighted Average Average Remaining Aggregate Number of Exercise Life Intrinsic Options Price In Years Value Outstanding, December 31, 2018 216,557 $ 3.51 8.26 $ - Granted 20,500,000 0.041 4.86 - Outstanding, September 30, 2019 20,716,557 $ 0.077 7.26 $ - Exercisable, September 30, 2019 20,716,557 $ 0.077 7.26 $ -
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Weighted Outstanding Average Exercisable Exercise Number of Remaining Life Number of Price Options In Years Options $ 0.24 208,160 7.75 208,160 $ 52.50 4,383 .75 4,383 $ 70.26 3,449 2.75 3,449 $ 420.00 565 1.65 565 $ 0.041 20,500,000 4.86 20,500,000 Total 20,716,557 4.89 20,716,557

Note 2 - Going Concern and Ma_2

Note 2 - Going Concern and Management's Plans (Details Textual) - USD ($)	3 Months Ended						9 Months Ended		49 Months Ended	52 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019	Sep. 30, 2019
Net Income (Loss) Attributable to Parent, Total	$ (935,388)	$ (285,850)	$ (298,323)	$ (279,823)	$ (189,664)	$ (338,554)	$ (1,519,561)	$ (808,041)		$ 5,159,369
Working Capital Deficit	3,407,441						3,407,441			$ 3,407,441
Revenue from Contract with Customer, Including Assessed Tax									$ 0

Note 3 - Summary of Significa_3

Note 3 - Summary of Significant Accounting Policies - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Total potentially dilutive shares (in shares)	273,938,433	169,248,473
Options [Member]
Total potentially dilutive shares (in shares)	20,716,557	2,883,379
Warrant [Member]
Total potentially dilutive shares (in shares)	61	1,061
Series A Convertible Preferred Stock [Member]
Total potentially dilutive shares (in shares)	115,000	115,000
Convertible Debt Securities [Member]
Total potentially dilutive shares (in shares)	253,106,815	166,249,033

Note 4 - Debentures and Notes_3

Note 4 - Debentures and Notes Payable (Details Textual) - USD ($)	Jun. 21, 2017	Mar. 30, 2017	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Apr. 18, 2016	Feb. 24, 2016	Jun. 01, 2015	Nov. 03, 2006
Notes Payable, Related Parties			$ 2,017,434	$ 2,017,434		$ 1,702,300
Amortization of Debt Discount (Premium)				$ 45,134	$ 135,333
Warrants Issued in Connection With November 2006 Connvertible Debenture [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights										61
Class of Warrant or Right, Exercise Price of Warrants or Rights										$ 114,450
Six Point Zero Five Percent Insurance Premium Finance Agreement, Due July 2019 [Member]
Debt Instrument, Interest Rate, Stated Percentage			6.05%	6.05%	6.05%	6.05%
Debt Instrument, Face Amount					$ 48,855
Debt Instrument, Periodic Payment, Total				$ 4,441
Repayments of Debt				$ 31,089
Six Point Three Percent Insurance Premium Finance Agreement [Member]
Debt Instrument, Interest Rate, Stated Percentage			6.30%	6.30%
Debt Instrument, Face Amount			$ 61,503	$ 61,503
Debt Instrument, Periodic Payment, Total			$ 5,591
Debt Instrument, Term				330 days
Four Point Seven Five Percent Convertible Debenture [Member]
Debt Instrument, Interest Rate, Stated Percentage			4.75%	4.75%		4.75%				4.75%
Debt Instrument, Face Amount										$ 100,000
Fourteen Percent Term Loan One [Member]
Debt Instrument, Interest Rate, Stated Percentage			14.00%	14.00%		14.00%
Notes Payable, Related Parties			$ 374,993	$ 374,993		$ 374,993
Fourteen Percent Term Loan One [Member] | Carlton James North Dakota Limited [Member]
Debt Instrument, Interest Rate, Stated Percentage							14.00%
Debt Agreement, Maximum Borrowing Capacity							$ 100,000
Debt Instrument, Interest Rate, Monthly							1.167%
Notes Payable, Related Parties			374,993	374,993
Debt Instrument, Advances in Excess of Facility Limit			$ 274,993	$ 274,993
Fourteen Percent Term Loan Two [Member]
Debt Instrument, Interest Rate, Stated Percentage			14.00%	14.00%		14.00%
Notes Payable, Related Parties			$ 756,500	$ 756,500		$ 621,500
Fourteen Percent Term Loan Two [Member] | Victor Keen [Member]
Notes Payable, Related Parties			756,500	756,500
Debt Instrument, Advances in Excess of Facility Limit			$ 456,500	$ 456,500
Fourteen Percent Term Loan Two [Member] | Co-chairman of Board of Directors [Member]
Debt Instrument, Interest Rate, Stated Percentage								14.00%
Debt Agreement, Maximum Borrowing Capacity								$ 300,000
Debt Instrument, Interest Rate, Monthly								1.167%
Fourteen percent Term Loan Three [Member]
Debt Instrument, Interest Rate, Stated Percentage			14.00%	14.00%		14.00%
Notes Payable, Related Parties			$ 535,941	$ 535,941		$ 400,941
Fourteen percent Term Loan Three [Member] | Carlton James North Dakota Limited [Member]
Notes Payable, Related Parties									$ 535,941
Debt Instrument, Advances in Excess of Facility Limit			$ 35,941	$ 35,941
Fourteen percent Term Loan Three [Member] | Carlton James North Dakota Limited [Member]
Debt Instrument, Interest Rate, Stated Percentage									14.00%
Debt Instrument, Face Amount									$ 500,000
Debt Instrument, Interest Rate, Monthly									1.167%
Seven Percent Convertible Promissory Note One [Member]
Debt Instrument, Interest Rate, Stated Percentage			7.00%	7.00%		7.00%
Notes Payable, Related Parties			$ 250,000	$ 250,000		$ 228,627
Seven Percent Convertible Promissory Note One [Member] | Co-chairman of Board of Directors [Member]
Amortization of Debt Discount (Premium)					97,830
Seven Percent Convertible Promissory Note One [Member] | Co-chairman of Board of Directors [Member]
Debt Instrument, Interest Rate, Stated Percentage		7.00%
Debt Instrument, Face Amount		$ 250,000
Debt Instrument, Convertible, Conversion Percentage		8.00%
Debt Instrument, Unamortized Discount, Total		$ 250,000
Amortization of Debt Discount (Premium)				$ 21,373
Seven Percent Convertible Promissory Note Two [Member]
Debt Instrument, Interest Rate, Stated Percentage			7.00%	7.00%		7.00%
Notes Payable, Related Parties			$ 100,000	$ 100,000		$ 76,239
Seven Percent Convertible Promissory Note Two [Member] | Co-chairman of Board of Directors [Member]
Amortization of Debt Discount (Premium)					$ 37,503
Seven Percent Convertible Promissory Note Two [Member] | Co-chairman of Board of Directors [Member]
Debt Instrument, Interest Rate, Stated Percentage	7.00%
Debt Instrument, Face Amount	$ 100,000
Debt Instrument, Convertible, Conversion Percentage	4.00%
Debt Instrument, Unamortized Discount, Total	$ 100,000
Amortization of Debt Discount (Premium)				$ 23,761

Note 4 - Debentures and Notes_4

Note 4 - Debentures and Notes Payable - Schedule of Debt (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Notes and debentures payable	$ 119,586	$ 94,764
Notes Payable, Related Parties	2,017,434	1,702,300
Six Point Zero Five Percent Insurance Premium Finance Agreement, Due July 2019 [Member]
Notes and debentures payable		31,089
Six Point Three Percent Insurance Premium Finance Agreement [Member]
Notes and debentures payable	55,911
Four Point Seven Five Percent Convertible Debenture [Member]
Notes and debentures payable	63,675	63,675
Fourteen Percent Term Loan One [Member]
Notes Payable, Related Parties	374,993	374,993
Fourteen Percent Term Loan Two [Member]
Notes Payable, Related Parties	756,500	621,500
Fourteen percent Term Loan Three [Member]
Notes Payable, Related Parties	535,941	400,941
Seven Percent Convertible Promissory Note One [Member]
Notes Payable, Related Parties	250,000	228,627
Seven Percent Convertible Promissory Note Two [Member]
Notes Payable, Related Parties	$ 100,000	$ 76,239

Note 4 - Debentures and Notes_5

Note 4 - Debentures and Notes Payable - Schedule of Debt (Details) (Parentheticals)	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018	Nov. 03, 2006
Six Point Zero Five Percent Insurance Premium Finance Agreement, Due July 2019 [Member]
Interest rate	6.05%	6.05%	6.05%
Six Point Three Percent Insurance Premium Finance Agreement [Member]
Interest rate	6.30%
Four Point Seven Five Percent Convertible Debenture [Member]
Interest rate	4.75%	4.75%		4.75%
Fourteen Percent Term Loan One [Member]
Interest rate	14.00%	14.00%
Fourteen Percent Term Loan Two [Member]
Interest rate	14.00%	14.00%
Fourteen percent Term Loan Three [Member]
Interest rate	14.00%	14.00%
Seven Percent Convertible Promissory Note One [Member]
Interest rate	7.00%	7.00%
Seven Percent Convertible Promissory Note Two [Member]
Interest rate	7.00%	7.00%

Note 5 - Commitments and Cont_3

Note 5 - Commitments and Contingencies (Details Textual) - USD ($)	1 Months Ended	9 Months Ended		60 Months Ended
	Aug. 31, 2019	Sep. 30, 2019	Sep. 30, 2018	Jul. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	20,500,000
Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture	$ 840,500
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	337.19%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.52%
Operating Lease, Expense		$ 17,820	$ 17,358
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term				5 years

Note 5 - Commitments and Cont_4

Note 5 - Commitments and Contingencies - Option Activity (Details) - $ / shares	1 Months Ended	9 Months Ended	12 Months Ended
	Aug. 31, 2019	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2019
Granted, Shares (in shares)	20,500,000
Share-based Payment Arrangement, Option [Member]
Outstanding, Shares (in shares)		216,557
Outstanding, Weighted Average Exercise Price (in dollars per share)		$ 3.51
Outstanding, Weighted Average Remaining Life (Year)		4 years 313 days	8 years 94 days
Granted, Shares (in shares)		20,500,000
Granted, Weighted Average Exercise Price (in dollars per share)		$ 0.041
Outstanding, Shares (in shares)		216,557	216,557	20,716,557
Outstanding, Weighted Average Exercise Price (in dollars per share)		$ 3.51	$ 3.51	$ 0.077
Outstanding, Weighted Average Remaining Life in Years (Year)		7 years 94 days
Exercisable, Shares (in shares)		20,716,557
Exercisable, Weighted Average Exercise Price (in dollars per share)		$ 0.077
Exercisable, Weighted Average Remaining Life (Year)		7 years 94 days

Note 5 - Commitments and Cont_5

Note 5 - Commitments and Contingencies - Shares Authorized Under Stock Option Plans (Details)	9 Months Ended
	Sep. 30, 2019$ / sharesshares
Option Outstanding, Number Of Options (in shares)	20,716,557
Option Exercisable ,Weighted Average Remaining Life In Years (Year) (Year)	4 years 324 days
Option Exercisable, Number Of Options (in shares)	20,716,557
Exercise Price Range One [Member]
Option Outstanding, Exercise Price (in dollars per share) | $ / shares	$ 0.24
Option Outstanding, Number Of Options (in shares)	208,160
Option Exercisable ,Weighted Average Remaining Life In Years (Year) (Year)	7 years 273 days
Option Exercisable, Number Of Options (in shares)	208,160
Exercise Price Range Two [Member]
Option Outstanding, Exercise Price (in dollars per share) | $ / shares	$ 52.50
Option Outstanding, Number Of Options (in shares)	4,383
Option Exercisable ,Weighted Average Remaining Life In Years (Year) (Year)	273 days
Option Exercisable, Number Of Options (in shares)	4,383
Exercise Price Range Three [Member]
Option Outstanding, Exercise Price (in dollars per share) | $ / shares	$ 70.26
Option Outstanding, Number Of Options (in shares)	3,449
Option Exercisable ,Weighted Average Remaining Life In Years (Year) (Year)	2 years 273 days
Option Exercisable, Number Of Options (in shares)	3,449
Exercise Price Range Four [Member]
Option Outstanding, Exercise Price (in dollars per share) | $ / shares	$ 420
Option Outstanding, Number Of Options (in shares)	565
Option Exercisable ,Weighted Average Remaining Life In Years (Year) (Year)	1 year 237 days
Option Exercisable, Number Of Options (in shares)	565
Exercise Price Range Five [Member]
Option Outstanding, Exercise Price (in dollars per share) | $ / shares	$ 0.041
Option Outstanding, Number Of Options (in shares)	20,500,000
Option Exercisable ,Weighted Average Remaining Life In Years (Year) (Year)	4 years 313 days
Option Exercisable, Number Of Options (in shares)	20,500,000

Note 6 - Subsequent Events (Det

Note 6 - Subsequent Events (Details Textual) - USD ($)	Oct. 15, 2019	Apr. 30, 2020	Jan. 01, 2021	Jan. 01, 2021	Jan. 01, 2021	Sep. 30, 2019	Dec. 31, 2018	Nov. 03, 2006
Forecast [Member] | Warrant Issued in Connection With Credit Agreement [Member] | Minimum [Member]
Class of Warrant or Right, Issued Monthly		150,000
Forecast [Member] | Warrant Issued in Connection With Credit Agreement [Member] | Maximum [Member]
Class of Warrant or Right, Issued Monthly		210,000
Credit Agreement And Note [Member] | Forecast [Member]
Line of Credit Facility, Commitment Fee Amount					$ 75,000
Proceeds from Issuance of Debt				$ 125,000
Line of Credit Principal Advance Installment Amount			$ 175,000
Four Point Seven Five Percent Convertible Debenture [Member]
Debt Instrument, Interest Rate, Stated Percentage						4.75%	4.75%	4.75%
Subsequent Event [Member] | Warrant Issued in Connection With Credit Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	3,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.052
Class of Warrant or Right Value Per Share	$ 0.0241
Class of Warrant or Right Estimated Value During Period	$ 72,300
Warrants and Rights Outstanding, Term	5 years
Subsequent Event [Member] | Warrant Issued in Connection With Credit Agreement [Member] | Measurement Input, Expected Dividend Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0
Subsequent Event [Member] | Warrant Issued in Connection With Credit Agreement [Member] | Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	342.48
Subsequent Event [Member] | Warrant Issued in Connection With Credit Agreement [Member] | Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input	1.58
Subsequent Event [Member] | Credit Agreement And Note [Member]
Proceeds from Debt, Net of Issuance Costs	$ 106,483
Line of Credit Facility, Commitment Fee Amount	3,750
Payments of Advance Interest On Debt	6,250
Legal Fees	8,157
Debt Agreement, Maximum Borrowing Capacity	2,500,000
Proceeds from Issuance of Debt	$ 125,000
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Line of Credit Facility, Commitment Fee Percentage	3.00%
Debt Instrument, Convertible, Conversion Price	$ 0.043
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	70.00%
Subsequent Event [Member] | Credit Agreement And Note [Member] | Warrant Issued in Connection With Credit Agreement [Member]
Warrants and Rights Outstanding	$ 3,615
Subsequent Event [Member] | Four Point Seven Five Percent Convertible Debenture [Member]
Debt Instrument, Interest Rate, Stated Percentage	4.75%
Extinguishment of Debt, Amount	$ 63,675
Retirement of Debt Interest	$ 23,565